Page last updated: 2024-10-21

4-aminopyridine and Polyneuropathies

4-aminopyridine has been researched along with Polyneuropathies in 1 studies

Polyneuropathies: Diseases of multiple peripheral nerves simultaneously. Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of polyneuropathy are categorized by the type of nerve affected (e.g., sensory, motor, or autonomic), by the distribution of nerve injury (e.g., distal vs. proximal), by nerve component primarily affected (e.g., demyelinating vs. axonal), by etiology, or by pattern of inheritance.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Claassen, J1
Feil, K1
Bardins, S1
Teufel, J1
Spiegel, R1
Kalla, R1
Schneider, E1
Jahn, K1
Schniepp, R1
Strupp, M1

Other Studies

1 other study available for 4-aminopyridine and Polyneuropathies

ArticleYear
Dalfampridine in patients with downbeat nystagmus--an observational study.
    Journal of neurology, 2013, Volume: 260, Issue:8

    Topics: 4-Aminopyridine; Aged; Aged, 80 and over; Brain; Delayed-Action Preparations; Eye Movements; Female;

2013